Arnold DM. Bleeding complications in immune thrombocytopenia. Hematology Am Soc Hematol Educ Prog. 2015;2015:237–42.

Article  Google Scholar 

Kashiwagi H, Kuwana M, Hato T, Takafuta T, Fujimura K, Kurata Y, et al. Reference guide for management of adult immune thrombocytopenia in Japan: 2019 Revision. Int J Hematol. 2020;111:329–51.

Article  PubMed  PubMed Central  Google Scholar 

Neunert C, Terrell DR, Arnold DM, Buchanan G, Cines DB, Cooper N, et al. American society of hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3:3829–66.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Provan D, Arnold DM, Bussel JB, Chong BH, Cooper N, Gernsheimer T, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv. 2019;3:3780–817.

Article  PubMed  PubMed Central  Google Scholar 

Brown TM, Horblyuk RV, Grotzinger KM, Matzdorff AC, Pashos CL. Patient-reported treatment burden of chronic immune thrombocytopenia therapies. BMC Blood Disord. 2012;12:2.

Article  PubMed  PubMed Central  Google Scholar 

Yasir M, Goyal A, Corticosteroid SS, Effects A. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023.

Google Scholar 

Berti D, Moons P, Dobbels F, Deuson R, Janssens A, De Geest S. Impact of corticosteroid-related symptoms in patients with immune thrombocytopenic purpura: results of a survey of 985 patients. Clin Ther. 2008;30:1540–52.

Article  PubMed  Google Scholar 

Strehl C, Bijlsma JW, de Wit M, Boers M, Caeyers N, Cutolo M, et al. Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force. Ann Rheum Dis. 2016;75:952–7.

Article  CAS  PubMed  Google Scholar 

Vestergaard P, Olsen ML, Paaske Johnsen S, Rejnmark L, Sørensen HT, Mosekilde L. Corticosteroid use and risk of hip fracture: a population-based case-control study in Denmark. J Intern Med. 2003;254:486–93.

Article  CAS  PubMed  Google Scholar 

George MD, Baker JF, Winthrop K, Hsu JY, Wu Q, Chen L, et al. Risk for serious infection with low-dose glucocorticoids in patients with Rheumatoid arthritis: a Cohort Study. Ann Intern Med. 2020;173:870–8.

Article  PubMed  PubMed Central  Google Scholar 

Trotter P, Hill QA. Immune thrombocytopenia: improving quality of life and patient outcomes. Patient Relat Outcome Meas. 2018;9:369–84.

Article  PubMed  PubMed Central  Google Scholar 

Mathias SD, Gao SK, Miller KL, Cella D, Snyder C, Turner R, et al. Impact of chronic immune thrombocytopenic purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective. Health Qual Life Outcomes. 2008;6:13.

Article  PubMed  PubMed Central  Google Scholar 

Terrell DR, Neunert CE, Cooper N, Heitink-Pollé KM, Kruse C, Imbach P, et al. Immune thrombocytopenia (ITP): current limitations in patient management. Medicina (Kaunas). 2020;56:667.

Article  PubMed  Google Scholar 

Matzdorff AC, Arnold G, Salama A, Ostermann H, Eberle S, Hummler S. Advances in ITP - therapy and quality of life - a patient survey. PLoS One. 2011;6: e27350.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wong TF, Majewska R, Tomiyama Y. Management of primary immune thrombocytopenia in a real-world setting in Japan: eltrombopag versus corticosteroids. Int J Hematol. 2021;114:152–63.

Article  CAS  PubMed  Google Scholar 

Kurata Y, Fujimura K, Kuwana M, Tomiyama Y, Murata M. Epidemiology of primary immune thrombocytopenia in children and adults in Japan: a population-based study and literature review. Int J Hematol. 2011;93:329–35.

Article  PubMed  Google Scholar 

Okada A, Yasunaga H. Prevalence of noncommunicable diseases in Japan using a newly developed administrative claims database covering young, middle-aged, and elderly people. JMA J. 2022;5:190–8.

PubMed  PubMed Central  Google Scholar 

Oray M, Abu Samra K, Ebrahimiadib N, Meese H, Foster CS. Long-term side effects of glucocorticoids. Expert Opin Drug Saf. 2016;15:457–65.

Article  CAS  PubMed  Google Scholar 

Bidot CJ, Jy W, Horstman LL, Ahn ER, Yaniz M, Ahn YS. Antiphospholipid antibodies (APLA) in immune thrombocytopenic purpura (ITP) and antiphospholipid syndrome (APS). Am J Hematol. 2006;81:391–6.

Article  CAS  PubMed  Google Scholar 

Pierrot-Deseilligny Despujol C, Michel M, Khellaf M, Gouault M, Intrator L, Bierling P, et al. Antiphospholipid antibodies in adults with immune thrombocytopenic purpura. Br J Haematol. 2008;142:638–43.

Article  PubMed  Google Scholar 

LaMoreaux B, Barbar-Smiley F, Ardoin S, Madhoun H. Two cases of thrombosis in patients with antiphospholipid antibodies during treatment of immune thrombocytopenia with romiplostim, a thrombopoietin receptor agonist. Semin Arthritis Rheum. 2016;45:e10–2.

Article  PubMed  Google Scholar 

Van de Vondel S, Vandenbriele C, Gheysens G, Verhamme P, Janssens A. Catastrophic antiphospholipid syndrome in an immune thrombocytopenia patient treated with avatrombopag. Res Pract Thromb Haemost. 2023;7: 100125.

Article  PubMed  PubMed Central  Google Scholar 

Mehta AR, Kefela A, Toste C, Sweet D. Real-world use of fostamatinib in patients with immune thrombocytopenia and thrombotic risk. Acta Haematol. 2022;145:221–8.

Article  CAS  PubMed  Google Scholar 

Price D, Castro M, Bourdin A, Fucile S, Altman P. Short-course systemic corticosteroids in asthma: striking the balance between efficacy and safety. Eur Respir Rev. 2020;29: 190151.

Article  PubMed  PubMed Central  Google Scholar 

Amiche MA, Abtahi S, Driessen JHM, Vestergaard P, de Vries F, Cadarette SM, et al. Impact of cumulative exposure to high-dose oral glucocorticoid on fracture risk in Denmark: a population-based case-control study. Arch Osteoporos. 2018;13:30.

Article  PubMed  PubMed Central  Google Scholar 

Portielje JE, Westendorp RG, Kluin-Nelemans HC, Brand A. Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood. 2001;97:2549–54.

Article  CAS  PubMed  Google Scholar 

Mingot-Castellano ME, Canaro Hirnyk M, Sánchez-González B, Álvarez-Román MT, Bárez-García A, Bernardo-Gutiérrez Á, et al. Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI). J Clin Med. 2023;12:6422.

Article  PubMed  PubMed Central  Google Scholar